Source:http://linkedlifedata.com/resource/pubmed/id/11557255
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-9-14
|
pubmed:abstractText |
The rationale for point-of-care testing is that more rapid provision of biochemical test results performed at the patients bedside will equate with better outcomes. For this to be the case, a number of conditions must be satisfied, and in particular the choice of appropriate markers, an adequate turnaround time (TAT), and an accurate measurement. Point-of-care testing of cardiac markers was found to reduce TAT from 72 (central laboratory) to 20 min thus allowing to decrease total hospital stay.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0009-8981
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
311
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
57-61
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading | |
pubmed:year |
2001
|
pubmed:articleTitle |
Point-of-care testing: a cardiologist's view.
|
pubmed:affiliation |
Department of Chemical Pathology, St George's Hospital, London SW17 0QT, UK. pstubbs@wgh.demon.uk
|
pubmed:publicationType |
Journal Article,
Review
|